Aspirin induces short-chain free fatty acid accumulation in rats

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 49-52

  Yoshida, Yoshihiro ^a   Wang, Shayan ^b   Osame, Mitsuhiro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Aspirin; Dicarboxylic acid; Fatty acid; Infarction; Salicylic acid; Serum; Short chain

Indexed keywords

ACETYLSALICYLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID METABOLISM; HEART INFARCTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RAT; REYE SYNDROME;

ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; ANIMALS; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, VOLATILE; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR;

EID: 0032524562     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00168-X     Document Type: Article

References (34)

1. Anonymous Reye's syndrome surveillance, United States. J. Am. Med. Assoc. 257:1987;2645-2648.
2. Antiplatelet Trialists' Collaboration Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 308:1994;81-106.
3. Aprille J.R., Kelley R.T., Brown C.A. Salicylate has several effects on mitochondrial function. J. Nation. Reye's Syndrome Found. 7:1986;65-93.
4. Arrowsmith J.B., Kennedy D.L., Kuritsky J.N., Faich G.A. National patterns of aspirin use and Reye syndrome. Reporting, United States, 1980 to 1985. Pediatrics. 79:1987;858-863.
5. Aspirin Myocardial Infarction Study Research Group A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. J. Am. Med. Assoc. 243:1980;661-669.
6. Bachmann C., Colombo J., Beruter J. Short chain fatty acids in plasma and brain: quantitative determination by gas chromatography. Clin. Chim. Acta. 92:1979;153-159.
7. Barnett H.J.M., Eliasziw M., Meldrum H.E. Drugs and surgery in the prevention of ischemic stroke. New Engl. J. Med. 332:1995;238-248.
8. Barrett M.J., Hurwitz E.S., Schonberger L.B., Rogers M.F. Changing epidemiology of Reye syndrome in the United States. Pediatrics. 77:1986;598-602.
9. Bourgeois C., Olson L., Comer D., Evans H., Keschamras N., Cotton R., Grossman R., Smith T. Encephalopathy and fatty degeneration of the viscera: clinicopathological analysis of 40 patients. Am. J. Clin. Pathol. 56:1971;558-571.
10. Brondy T.M. Action of sodium salicylate and related compounds on tissue metabolism in vitro. J. Pharmacol. Exp. Ther. 117:1956;39-51.
11. Brown R.E., Forman D.T. The biochemistry of Reye's syndrome. Crit. Rev. Clin. Lab. Sci. 17:1982;247-297.
12. DeDivo D.C. Reye's syndrome: a metabolic response to an acute mitochondrial insult. Neurology. 28:1978;105-108.
13. Hart R.G., Harrison J.G. Aspirin wars. The optimal dose of aspirin to prevent stroke. Stroke. 27:1996;585-591.
14. Hurwitz E.S., Barrett M.J., Bregman D., Gunn W.J., Pinsky P., Schonberger L.B., Drage J.S., Kaslow R.A., Burlington D.B., Quinnan G.V., LaMontagne J.R., Fairweather W.R. Public health service study of Reye's syndrome and medications. Report of the main study. J. Am. Med. Assoc. 257:1987;1905-1911.
15. Jolley M.E., Stroupe S.D., Schwenzer K.S., Wang C.J., Lu-Steffes M., Hill H.D., Popelka S.R., Holen J.T., Kelso D.M. Fluorescence polarization immunoassay: III. An automated system for therapeutic drug determination. Clin. Chem. 27:1981;1575-1579.
16. Kallmann R., Nieuwenhuis H.K., de Groot P.G., van Gijin J., Sixma J.J. Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1α excretion in healthy subjects. Thromb. Res. 45:1987;355-361.
17. Kundu R.K., Tonsgard J.H., Getz G.S. Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid. J. Clin. Invest. 88:1991;1865-1872.
18. Malewitcz B., Parathasarthy S., Jenkin H.M., Baumann W.J. Rapid phospholipase A stimulation and diacylglycerol choline phosphotransferase inhibition in baby hamster kidney cells during initiation of Dengue virus infection. Biochem. Biophys. Res. Commun. 104:1981;404-410.
19. Matchar D.B., McCroy D.C., Barnett H.J.M., Feussner J.R. Medical treatment for stroke prevention. Ann. Intern. Med. 121:1994;41-53.
20. Moncada S., Vane J.R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. New Engl. J. Med. 300:1979;1142-1147.
21. Mortensen P.B. Formation and degradation of dicarboxylic acids in relation to alterations in fatty acid oxidation in rats. Biochim. Biophys. Acta. 1124:1992;71-79.
22. Ng K.J., Andersen B.D., Hilty M.D., Bianchine J.R. Identification of long chain dicarboxylic acids in the serum of two patients with Reye's syndrome. J. Chromatogr. 276:1983;1-10.
23. Ogburn P.L., Sharp H., Lloyd-Still J.D., Johnson S.B., Holman R.T. Abnormal polyunsaturated fatty acid patterns of serum lipids in Reye's syndrome. Proc. Natl. Acad. Sci. USA. 79:1982;908-911.
24. Okita R. Effect of acetylsalicylic acid on fatty acid ω-hydroxylation in rat liver. Pediatr. Res. 20:1986;1221-1224.
25. Patrono C., Roth G.J. Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen? Stroke. 27:1996;756-760.
26. Peto R., Gray R., Collins R., Wheatley K., Hennekens C., Jamrozik S., Gilliland J., Doll R. Randomized trial of prophylactic daily aspirin in British male doctors. Br. Med. J. 296:1988;313-331.
27. Pirofski L., Horwitz M.S., Scharff M.D., Factor S.M. Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome. Proc. Natl. Acad. Sci. USA. 88:1991;4358-4362.
28. Reye R.D.K., Morgan G., Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity of childhood. Lancet. ii:1963;749-752.
29. The Grupo Espanol para el Seguimientoo del Injerto Corlnario (GESIC), Sanz G., Pajaron A., Alegria E., Coello I., Cardona M., Fournier J.A., Gomez-Recio M., Ruano J., Hidalgo R., Medina A., Oller G., Coleman T., Malpartida F., Bosch X. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Circulation. 82:1990;765-773.
30. Singh A.K., Yoshida Y., Garvin A.J., Singh I. Effect of fatty acids and their derivatives on mitochondrial structures. J. Exp. Pathol. 4:1989;9-15.
31. Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing physicians' health study. New Engl. J. Med. 321:1989;129-135.
32. Tonsgard J.H., Getz G.S. Effect of Reye's syndrome serum on isolated Chinchilla liver mitochondria. J. Clin. Invest. 76:1985;816-825.
33. Trauner D., Sweetman L., Holm J., Kulovich S., Nyhan W. Biochemical correlates of illness and recovery in Reye's syndrome. Ann. Neurol. 2:1977;238-241.
34. Yoshida Y., Fujii M., Brown III F.R., Singh I. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. Pediatr. Res. 23:1988;338-341.